125 related articles for article (PubMed ID: 36611064)
1. Deubiquitinase catalytic activity of MYSM1 is essential in vivo for hematopoiesis and immune cell development.
Liang Y; Bhatt G; Tung LT; Wang H; Kim JE; Mousa M; Plackoska V; Illes K; Georges AA; Gros P; Henneman L; Huijbers IJ; Nagar B; Nijnik A
Sci Rep; 2023 Jan; 13(1):338. PubMed ID: 36611064
[TBL] [Abstract][Full Text] [Related]
2. Chromatin-binding deubiquitinase MYSM1 acts in haematopoietic progenitors to control dendritic cell development and to program dendritic cell responses to microbial stimulation.
Mousa M; Liang Y; Tung LT; Wang H; Krawczyk C; Langlais D; Nijnik A
Immunology; 2024 May; 172(1):109-126. PubMed ID: 38316548
[TBL] [Abstract][Full Text] [Related]
3. Deubiquitinase MYSM1 in the Hematopoietic System and beyond: A Current Review.
Fiore A; Liang Y; Lin YH; Tung J; Wang H; Langlais D; Nijnik A
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32344625
[TBL] [Abstract][Full Text] [Related]
4. An in vivo genetic reversion highlights the crucial role of Myb-Like, SWIRM, and MPN domains 1 (MYSM1) in human hematopoiesis and lymphocyte differentiation.
Le Guen T; Touzot F; André-Schmutz I; Lagresle-Peyrou C; France B; Kermasson L; Lambert N; Picard C; Nitschke P; Carpentier W; Bole-Feysot C; Lim A; Cavazzana M; Callebaut I; Soulier J; Jabado N; Fischer A; de Villartay JP; Revy P
J Allergy Clin Immunol; 2015 Dec; 136(6):1619-1626.e5. PubMed ID: 26220525
[TBL] [Abstract][Full Text] [Related]
5. Mysm1 expression in the bone marrow niche is not essential for hematopoietic maintenance.
Petrov JC; Nijnik A
Exp Hematol; 2017 Mar; 47():76-82.e3. PubMed ID: 27833034
[TBL] [Abstract][Full Text] [Related]
6. Interplay of H2A deubiquitinase 2A-DUB/Mysm1 and the p19(ARF)/p53 axis in hematopoiesis, early T-cell development and tissue differentiation.
Gatzka M; Tasdogan A; Hainzl A; Allies G; Maity P; Wilms C; Wlaschek M; Scharffetter-Kochanek K
Cell Death Differ; 2015 Sep; 22(9):1451-62. PubMed ID: 25613381
[TBL] [Abstract][Full Text] [Related]
7. The critical role of histone H2A-deubiquitinase Mysm1 in hematopoiesis and lymphocyte differentiation.
Nijnik A; Clare S; Hale C; Raisen C; McIntyre RE; Yusa K; Everitt AR; Mottram L; Podrini C; Lucas M; Estabel J; Goulding D; ; ; Adams N; Ramirez-Solis R; White JK; Adams DJ; Hancock RE; Dougan G
Blood; 2012 Feb; 119(6):1370-9. PubMed ID: 22184403
[TBL] [Abstract][Full Text] [Related]
8. Deubiquitinase MYSM1 Is Essential for Normal Fetal Liver Hematopoiesis and for the Maintenance of Hematopoietic Stem Cells in Adult Bone Marrow.
Förster M; Belle JI; Petrov JC; Ryder EJ; Clare S; Nijnik A
Stem Cells Dev; 2015 Aug; 24(16):1865-77. PubMed ID: 26125289
[TBL] [Abstract][Full Text] [Related]
9. MYSM1 maintains ribosomal protein gene expression in hematopoietic stem cells to prevent hematopoietic dysfunction.
Belle JI; Wang H; Fiore A; Petrov JC; Lin YH; Feng CH; Nguyen TTM; Tung J; Campeau PM; Behrends U; Brunet T; Leszinski GS; Gros P; Langlais D; Nijnik A
JCI Insight; 2020 Jul; 5(13):. PubMed ID: 32641579
[TBL] [Abstract][Full Text] [Related]
10. p53 mediates loss of hematopoietic stem cell function and lymphopenia in Mysm1 deficiency.
Belle JI; Langlais D; Petrov JC; Pardo M; Jones RG; Gros P; Nijnik A
Blood; 2015 Apr; 125(15):2344-8. PubMed ID: 25710881
[TBL] [Abstract][Full Text] [Related]
11. Further delineation of bone marrow failure syndrome caused by novel compound heterozygous variants of MYSM1.
Li N; Xu Y; Yu T; Yao R; Chen J; Luo C; Wang J
Gene; 2020 Oct; 757():144938. PubMed ID: 32640305
[TBL] [Abstract][Full Text] [Related]
12. Deubiquitinase Mysm1 regulates neural stem cell proliferation and differentiation by controlling Id4 expression.
Xu Z; Qin Q; Wang Y; Zhang H; Liu S; Li X; Chen Y; Wang Y; Ruan H; He W; Zhang T; Yan X; Wang C; Xu D; Jiang X
Cell Death Dis; 2024 Feb; 15(2):129. PubMed ID: 38342917
[TBL] [Abstract][Full Text] [Related]
13. Interaction of Deubiquitinase 2A-DUB/MYSM1 with DNA Repair and Replication Factors.
Kroeger C; Roesler R; Wiese S; Hainzl A; Gatzka MV
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32466590
[TBL] [Abstract][Full Text] [Related]
14. MYSM1 Is Essential for Maintaining Hematopoietic Stem Cell (HSC) Quiescence and Survival.
Huo Y; Li BY; Lin ZF; Wang W; Jiang XX; Chen X; Xi WJ; Yang AG; Chen SY; Wang T
Med Sci Monit; 2018 Apr; 24():2541-2549. PubMed ID: 29694335
[TBL] [Abstract][Full Text] [Related]
15. Repression of p53-target gene Bbc3/PUMA by MYSM1 is essential for the survival of hematopoietic multipotent progenitors and contributes to stem cell maintenance.
Belle JI; Petrov JC; Langlais D; Robert F; Cencic R; Shen S; Pelletier J; Gros P; Nijnik A
Cell Death Differ; 2016 May; 23(5):759-75. PubMed ID: 26768662
[TBL] [Abstract][Full Text] [Related]
16. Human hematopoietic stem cell vulnerability to ferroptosis.
Zhao J; Jia Y; Mahmut D; Deik AA; Jeanfavre S; Clish CB; Sankaran VG
Cell; 2023 Feb; 186(4):732-747.e16. PubMed ID: 36803603
[TBL] [Abstract][Full Text] [Related]
17. MYSM1-dependent checkpoints in B cell lineage differentiation and B cell-mediated immune response.
Förster M; Farrington K; Petrov JC; Belle JI; Mindt BC; Witalis M; Duerr CU; Fritz JH; Nijnik A
J Leukoc Biol; 2017 Mar; 101(3):643-654. PubMed ID: 27895164
[TBL] [Abstract][Full Text] [Related]
18. MYSM1 Represses Innate Immunity and Autoimmunity through Suppressing the cGAS-STING Pathway.
Tian M; Liu W; Zhang Q; Huang Y; Li W; Wang W; Zhao P; Huang S; Song Y; Shereen MA; Qin M; Liu Y; Wu K; Wu J
Cell Rep; 2020 Oct; 33(3):108297. PubMed ID: 33086059
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic control of dendritic cell development and fate determination of common myeloid progenitor by Mysm1.
Won H; Nandakumar V; Yates P; Sanchez S; Jones L; Huang XF; Chen SY
Blood; 2014 Oct; 124(17):2647-56. PubMed ID: 25217698
[TBL] [Abstract][Full Text] [Related]
20. Myb-like, SWIRM, and MPN domains 1 (MYSM1) deficiency: Genotoxic stress-associated bone marrow failure and developmental aberrations.
Bahrami E; Witzel M; Racek T; Puchałka J; Hollizeck S; Greif-Kohistani N; Kotlarz D; Horny HP; Feederle R; Schmidt H; Sherkat R; Steinemann D; Göhring G; Schlegelbeger B; Albert MH; Al-Herz W; Klein C
J Allergy Clin Immunol; 2017 Oct; 140(4):1112-1119. PubMed ID: 28115216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
